Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for ACAD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2000. Start Trial.
Date Value
December 31, 2025 819.69M
December 31, 2024 755.99M
December 31, 2023 438.86M
December 31, 2022 416.82M
December 31, 2021 520.71M
December 31, 2020 631.96M
December 31, 2019 697.43M
December 31, 2018 473.52M
December 31, 2017 341.34M
December 31, 2016 529.04M
December 31, 2015 215.13M
December 31, 2014 322.49M
December 31, 2013 185.79M
Date Value
December 31, 2012 107.97M
December 31, 2011 31.05M
December 31, 2010 37.09M
December 31, 2009 47.06M
December 31, 2008 60.08M
December 31, 2007 126.86M
December 31, 2006 83.26M
December 31, 2005 55.52M
December 31, 2004 35.93M
December 31, 2003 52.98M
December 31, 2002 12.44M
December 31, 2001 17.83M
December 31, 2000 28.90M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Incyte Corp. 3.581B
Agios Pharmaceuticals, Inc. 854.42M
Biogen, Inc. 3.816B
Insmed, Inc. 1.430B
Vertex Pharmaceuticals, Inc. 6.611B